4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-23-000041
CHIEF EXECUTIVE OFFICER acquired 5,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2022-12-30 | Grant or award | +5,000 | $0.09 | $438 | 158,998 | D |
Loading xslF345X03/form4-01032023_090116.xml…